Edition:
United States

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.50USD
3:59pm EST
Change (% chg)

$0.09 (+21.65%)
Prev Close
$0.41
Open
$0.42
Day's High
$0.50
Day's Low
$0.42
Volume
4,772,322
Avg. Vol
1,610,416
52-wk High
$2.85
52-wk Low
$0.12

Chart for

About

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including... (more)

Overall

Beta: 0.45
Market Cap(Mil.): $30.41
Shares Outstanding(Mil.): 73.85
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 187.16 16.73
EPS (TTM): -- -- --
ROI: -- -0.71 35.60
ROE: -- -3.52 17.23

BRIEF-Alpha Capital Anstalt Reports 9.9 Pct Passive Stake In Akers Biosciences

* ALPHA CAPITAL ANSTALT REPORTS 9.9 PERCENT PASSIVE STAKE IN AKERS BIOSCIENCES INC AS ON DECEMBER 21 - SEC FILING Source text (http://bit.ly/2BZ9Q04) Further company coverage:

Dec 22 2017

BRIEF-Akers Biosciences - Accutest Solutions secured new channel partner for sales​

* Akers Biosciences - ‍announces Accutest Solutions a distributor of Akers Bio's breathscan alcohol detector in UK, secured new channel partner for sales​

Nov 14 2017

Earnings vs. Estimates